Medicated Skin Care in Belgium
Euromonitor International's Medicated Skin Care in Belgium market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 36 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN BELGIUM : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - BELGIUM
BIODIPHAR NV SA - OTC HEALTHCARE - BELGIUM
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Biodiphar SA: Key Facts
Summary 2 Biodiphar SA: Operational Indicators
COMPANY BACKGROUND AND PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Biodiphar SA: Competitive Position 2008
OMEGA PHARMA NV - OTC HEALTHCARE - BELGIUM
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Omega Pharma NV: Key Facts
Summary 5 Omega Pharma NV: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 6 Omega Pharma NV: Production Statistics 2005
COMPETITIVE POSITIONING
Summary 7 Omega Pharma NV: Competitive Position 2008
PATCH PHARMA SA - OTC HEALTHCARE - BELGIUM
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Patch Pharma NV SA: Key Facts
COMPANY BACKGROUND AND PRODUCTION
COMPETITIVE POSITIONING
PHARMACEUTIQUES TRENKER, LABORATOIRES - OTC HEALTHCARE - BELGIUM
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Pharmaceutiques Trenker, Laboratoires: Key Facts
Summary 10 Pharmaceutiques Trenker, Laboratoires: Operational Indicators
COMPANY BACKGROUND AND PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Pharmaceutiques Trenker, Laboratoires: Competitive Position 2008
VEMEDIA PHARMA NV - OTC HEALTHCARE - BELGIUM
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Vemedia Pharma NV: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 13 Vemedia Pharma NV: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 14 Vemedia Pharma NV: Competitive Position 2008
OTC HEALTHCARE IN BELGIUM
EXECUTIVE SUMMARY
Disappointing results in 2008 after strong growth in 2007
Manufacturers focus on leading brands in restrictive environment
Market still fragmented, despite growing global consolidation
Pharmacies still monopolise distribution, despite beginning of deregulation
Rather bleak outlook in the short term
KEY TRENDS AND DEVELOPMENTS
Bleak prospects for economy, policy and thus purchasing power
A more favourable environment for OTC healthcare despite continuing conservatism
Mixed results for segmentation
Consumer lifestyles impact OTC formats
Related markets increasingly overlap with OTC
Beginning of deregulation and the emergence of Internet sales, but no real change in the dominance of chemists/pharmacies
Less room to manoeuvre for smaller players
MARKET INDICATORS
Table 11 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 12 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 13 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 14 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 15 OTC Healthcare Company Shares by Value 2004-2008
Table 16 OTC Healthcare Brand Shares by Value 2005-2008
Table 17 Penetration of Private Label by Sector 2003-2008
Table 18 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 19 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 20 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 21 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-listing Or De-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
The role played by the Belgian government
Trend reversal over the 2006-2008 period
Alternative Therapy
Lobbying and consumer loyalty ensure the ongoing success of homeopathy
Other alternative therapies impacted by fashion
Generics
Switches
DEFINITIONS
Sources
Summary 15 Research Sources